Darwin Wealth Management
RMD icon

Darwin Wealth Management’s ResMed RMD Stock Holding History

Darwin Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.6K Buy
+75
New +$16.4K ﹤0.01% 551
2020
Q2 		– Sell
-60
Closed -$8K – 629
2020
Q1 		$8K Buy
+60
New +$9.6K ﹤0.01% 523

Other funds holding RMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Darwin Wealth Management's RMD Position: Q3 2026 in Review

Darwin Wealth Management opened a new position in ResMed (RMD) in Q3 2026: 75 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #551 among its holdings. This is a return to the name: Darwin Wealth Management previously reported a position in RMD as recently as Q1 2020.

Darwin Wealth Management first reported a position in RMD in Q1 2020 and has held it in 2 quarters since. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Darwin Wealth Management held 75 shares of ResMed worth $16.6K as of Q3 2026.
  • ResMed was a new Darwin Wealth Management position in Q3 2026.
  • ResMed made up ﹤0.01% of Darwin Wealth Management's portfolio in Q3 2026, its #551 holding.
  • Darwin Wealth Management first reported a position in ResMed in Q1 2020 and has held it in 2 quarters since.
  • 535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.